FAIM
SGEN

Financial Advocates Investment Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Financial Advocates Investment Management’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,224
Closed -$208K – 696
2020
Q2 		$208K Buy
+1,224
New +$183K 0.02% 559

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Financial Advocates Investment Management's SGEN Position: Q3 2020 in Review

Financial Advocates Investment Management sold out of Seagen Inc. Common Stock (SGEN) in Q3 2020, closing a stake of 1,224 shares — an estimated $208K sold.

Financial Advocates Investment Management first reported a position in SGEN in Q2 2020 and held it in 1 quarter. The position peaked at $208K in Q2 2020. 435 funds tracked by Wall St. Rank hold SGEN as of Q3 2020.

  • Financial Advocates Investment Management reported no remaining Seagen Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Financial Advocates Investment Management sold 1,224 Seagen Inc. Common Stock shares in Q3 2020, an estimated $208K.
  • Financial Advocates Investment Management first reported a position in Seagen Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Financial Advocates Investment Management's Seagen Inc. Common Stock position peaked at $208K in Q2 2020.
  • 435 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2020.

Based on Financial Advocates Investment Management's 13F filing for Q3 2020, filed 4 Nov 2020.